GPX4 and neoplasm: TRIM36, a novel androgen-responsive gene, has been shown to regulate tumor plasticity in neuroendocrine prostate cancer (NEPC) by repressing glutathione peroxidase 4 (GPx4) expression in a manner dependent on HK2 ubiquitination.